Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Structural Heart Disease
    • TAVR
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025

Search form

Home

News You Need to Know Today
How cardiologists can boost surgery volumes | Spreading the word about CKM syndrome | Fitness trackers & cardiovascular health
Tuesday, August 12, 2025
Link to Twitter Link to Facebook Link to Linkedin Link to Vimeo

Today's News and Trends

How interventional cardiologists can boost cardiac surgery volumes

Competition was once fierce between interventional cardiologists and cardiac surgeons, but that has changed over the years. "It is absolutely a partnership," one veteran surgeon told Cardiovascular Business. 

READ MORE >
John Puskas, MD, MSc, PhD., FACS, FACC, professor of surgery, and chief of cardiothoracic surgery at Emory University Hospital Midtown, explains how interventional cardiologists can play a role in increasing referrals for coronary artery bypass graft (CABG) surgery for patients who are best suited for the procedure, as opposed to percutaneous coronary intervention (PCI). As the heart team approach expands across cardiology, with surgeons and interventionalists making more decisions together.
Share on Twitter Share on Facebook Share on Linkedin

How interventional cardiologists can boost cardiac surgery volumes

Share on Twitter Share on Facebook Share on Linkedin
John Puskas, MD, MSc, PhD., FACS, FACC, professor of surgery, and chief of cardiothoracic surgery at Emory University Hospital Midtown, explains how interventional cardiologists can play a role in increasing referrals for coronary artery bypass graft (CABG) surgery for patients who are best suited for the procedure, as opposed to percutaneous coronary intervention (PCI). As the heart team approach expands across cardiology, with surgeons and interventionalists making more decisions together.
Competition was once fierce between interventional cardiologists and cardiac surgeons, but that has changed over the years. "It is absolutely a partnership," one veteran surgeon told Cardiovascular Business. 
READ MORE >

AHA expands efforts to spread the word about CKM syndrome

This is a rapidly growing area of interest in cardiology as research continues to find close links between heart disease and kidney disease.

READ MORE >
AHA Cardiovascular-Kidney-Metabolic Health Initiative regions as of July 2025.
Share on Twitter Share on Facebook Share on Linkedin

AHA expands efforts to spread the word about CKM syndrome

Share on Twitter Share on Facebook Share on Linkedin
AHA Cardiovascular-Kidney-Metabolic Health Initiative regions as of July 2025.
This is a rapidly growing area of interest in cardiology as research continues to find close links between heart disease and kidney disease.
READ MORE >

Researchers use wearable fitness trackers to monitor sleep, CVD risk

A new two-year study is focused on the potential of using commercially available fitness trackers to identify patients who may face an increased risk of CVD.

READ MORE >
Functional magnetic resonance imaging can offer providers insight into brain connectivity abnormalities and how they correlate with cognitive impairments observed in patients with insomnia. #insomnia #troublesleeping
Share on Twitter Share on Facebook Share on Linkedin

Researchers use wearable fitness trackers to monitor sleep, CVD risk

Share on Twitter Share on Facebook Share on Linkedin
Functional magnetic resonance imaging can offer providers insight into brain connectivity abnormalities and how they correlate with cognitive impairments observed in patients with insomnia. #insomnia #troublesleeping
A new two-year study is focused on the potential of using commercially available fitness trackers to identify patients who may face an increased risk of CVD.
READ MORE >

Featured Articles

Another win for Lilly: Oral GLP-1 drug linked to significant weight loss, other cardiovascular benefits

Tirzepatide and semaglutide are getting the attention now, but orforglipron could be the next go-to drug for patients hoping to lose weight and improve their heart health—no injections required.

READ MORE >
weight loss scale overweight obese lose weight pounds
Share on Twitter Share on Facebook Share on Linkedin

Another win for Lilly: Oral GLP-1 drug linked to significant weight loss, other cardiovascular benefits

Share on Twitter Share on Facebook Share on Linkedin
weight loss scale overweight obese lose weight pounds
Tirzepatide and semaglutide are getting the attention now, but orforglipron could be the next go-to drug for patients hoping to lose weight and improve their heart health—no injections required.
READ MORE >

Air purifiers may reduce cardiovascular risks from pollution and wildfires

Multiple studies in recent years have linked poor air quality to significant cardiac risks. Air filters, however, have shown potential to help combat these risks.

READ MORE >
Wildfire pollution image. Photo courtesy of the American Heart Association.
Share on Twitter Share on Facebook Share on Linkedin

Air purifiers may reduce cardiovascular risks from pollution and wildfires

Share on Twitter Share on Facebook Share on Linkedin
Wildfire pollution image. Photo courtesy of the American Heart Association.
Multiple studies in recent years have linked poor air quality to significant cardiac risks. Air filters, however, have shown potential to help combat these risks.
READ MORE >

Texas cardiologist to pay $1.2M for allegedly prescribing opioids to himself

The interventional cardiologist was accused of prescribing a variety of drugs to his family and friends, but then picking them up himself for his own personal use. This settlement officially resolves those allegations. 

READ MORE >
pain pills opioids
Share on Twitter Share on Facebook Share on Linkedin

Texas cardiologist to pay $1.2M for allegedly prescribing opioids to himself

Share on Twitter Share on Facebook Share on Linkedin
pain pills opioids
The interventional cardiologist was accused of prescribing a variety of drugs to his family and friends, but then picking them up himself for his own personal use. This settlement officially resolves those allegations. 
READ MORE >

In Case You Missed It

FDA clears first robotically guided EP mapping catheter for ablation

Stereotaxis has received FDA clearance for the first mapping catheter of its kind. The company emphasized that this is just the first of many robotically navigated devices it is working to bring to the U.S. market.

READ MORE >
Stereotaxis MAGIC SWEEP electrophysiology catheter
Share on Twitter Share on Facebook Share on Linkedin

FDA clears first robotically guided EP mapping catheter for ablation

Share on Twitter Share on Facebook Share on Linkedin
Stereotaxis MAGIC SWEEP electrophysiology catheter
Stereotaxis has received FDA clearance for the first mapping catheter of its kind. The company emphasized that this is just the first of many robotically navigated devices it is working to bring to the U.S. market.
READ MORE >

Edwards Lifesciences loses TAVR leader to robotics firm, announces replacement

The change comes at a momentous time for the company's TAVR portfolio, which made history in May by receiving the very first FDA approval for treating asymptomatic severe AS.

READ MORE >
Larry Wood
Share on Twitter Share on Facebook Share on Linkedin

Edwards Lifesciences loses TAVR leader to robotics firm, announces replacement

Share on Twitter Share on Facebook Share on Linkedin
Larry Wood
The change comes at a momentous time for the company's TAVR portfolio, which made history in May by receiving the very first FDA approval for treating asymptomatic severe AS.
READ MORE >

New drug candidate for AFib fails in first-in-human trial—in fact, it made matters worse

Researchers had thought 2-HOBA might reduce the risk of AFib recurrence after catheter ablation procedures. What they found, however, was that treatment with the compound was actually harmful for patients instead of helpful. 

READ MORE >
pharmaceutical drug approval process
Share on Twitter Share on Facebook Share on Linkedin

New drug candidate for AFib fails in first-in-human trial—in fact, it made matters worse

Share on Twitter Share on Facebook Share on Linkedin
pharmaceutical drug approval process
Researchers had thought 2-HOBA might reduce the risk of AFib recurrence after catheter ablation procedures. What they found, however, was that treatment with the compound was actually harmful for patients instead of helpful. 
READ MORE >

In Other News

Medical journal bucks RFK, refuses to retract Danish vaccine study

A study analyzing data on 1.2 million children over two decades found no evidence that aluminum ingredients in vaccines cause autism or autoimmune disorders. HHS Secretary Robert F. Kennedy Jr. called the research “deceitful propaganda.”

READ MORE >
Trump and Robert F. Kennedy Jr., secretary of health and human services (HHS). White House press photo
Share on Twitter Share on Facebook Share on Linkedin

Medical journal bucks RFK, refuses to retract Danish vaccine study

Share on Twitter Share on Facebook Share on Linkedin
Trump and Robert F. Kennedy Jr., secretary of health and human services (HHS). White House press photo
A study analyzing data on 1.2 million children over two decades found no evidence that aluminum ingredients in vaccines cause autism or autoimmune disorders. HHS Secretary Robert F. Kennedy Jr. called the research “deceitful propaganda.”
READ MORE >

Radiologists say bill to grant pharmacists more authority could have ‘dangerous long-term consequences’

Bipartisan senators recently reintroduced the Equitable Community Access to Pharmacist Services Act, which could help fill care gaps in rural geographies. 

READ MORE >
Pharmacy
Share on Twitter Share on Facebook Share on Linkedin

Radiologists say bill to grant pharmacists more authority could have ‘dangerous long-term consequences’

Share on Twitter Share on Facebook Share on Linkedin
Pharmacy
Bipartisan senators recently reintroduced the Equitable Community Access to Pharmacist Services Act, which could help fill care gaps in rural geographies. 
READ MORE >

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us  |  Unsubscribe from all  |  Privacy Policy

© Innovate Healthcare, a TriMed Media brand
Innovate Healthcare

Recent Newsletters

CMS proposes major TAVR changes | The real impact of RVU cuts in electrophysiology | Girl’s heart valve implanted upside down
News Alert: CMS proposes major TAVR changes
Cath lab kits recalled | Looking ahead to the future of FFR-CT | Medtronic completes major acquisition
FDA sees potential in heart failure software | SCCT & SCAI take on CT-derived FFR | Predicting long-term stroke risk
Abbott recalls heart monitoring tech | Redo TAVR with balloon-expandable valves | FDA clears new clot-removing device
Week in Review: Star Trek star's family awarded $13M | AI for cardiac amyloidosis | TAVR concerns | New CKM syndrome guidelines
A brand new payment model | Cardiologist compensation keeps rising | Major medtech player invests $1.5B in TAVR tech

Pagination

    • First page « First
    • Previous page ‹‹
    • Page 1
    • Page 2
    • Page 3
    • Current page 4
    • Page 5
    • Page 6
    • Page 7
    • Page 8
    • Page 9 …
    • Next page ››
    • Last page Last »
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
 
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
 
Design by Adaptive Theme
Trimed Popup